Literature DB >> 8655650

Recognition and processing of damaged DNA.

T Lindahl1.   

Abstract

Base excision-repair, which is required for correction of spontaneous hydrolytic and oxidative damage to DNA as well as lesions inflicted by alkylating agents, is a relatively well understood repair pathway. Mammalian factors involved in this pathway are reviewed, with emphasis on current uncertainties. Most DNA replication and repair enzymes in mammalian cell nuclei, e.g. DNA polymerases alpha, beta, delta, and epsilon, have direct counterparts in yeast. In contrast, the abundant enzymes in mammalian cell nuclei that bind and are activated specifically by DNA strand interruptions, poly(ADP-ribose) polymerase and DNA-dependent protein kinase, have not been detected in yeast; nor has p53, which is elevated in response to DNA strand breaks. We have found a family of four distinct DNA ligases in human cell nuclei, whereas only a single DNA ligase has been detected in yeast. It would appear that the cellular responses to DNA strand breaks may differ markedly between higher and lower eukaryotes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8655650     DOI: 10.1242/jcs.1995.supplement_19.10

Source DB:  PubMed          Journal:  J Cell Sci Suppl        ISSN: 0269-3518


  13 in total

1.  Mixed spermatogenic germ cell nuclear extracts exhibit high base excision repair activity.

Authors:  G W Intano; C A McMahan; R B Walter; J R McCarrey; C A Walter
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

2.  Site-directed photoproteolysis of 8-oxoguanine DNA glycosylase 1 (OGG1) by specific porphyrin-protein probe conjugates: a strategy to improve the effectiveness of photodynamic therapy for cancer.

Authors:  Kimberly A Conlon; Miguel Berrios
Journal:  J Photochem Photobiol B       Date:  2006-12-15       Impact factor: 6.252

3.  The association of APE1 Asp148Glu gene polymorphisms and lung cancer risk: an updated meta-analysis.

Authors:  Wen Chen; Qin Wang; Mang Liu; Xiao-bing Ding
Journal:  Tumour Biol       Date:  2013-12-06

4.  The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis.

Authors:  Erdong Shen; Chuan Liu; Li Wei; Jianbing Hu; Jie Weng; Qinghua Yin; Yajie Wang
Journal:  Tumour Biol       Date:  2013-11-20

Review 5.  Accumulation of nuclear DNA damage or neuron loss: molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases.

Authors:  Ivona Brasnjevic; Patrick R Hof; Harry W M Steinbusch; Christoph Schmitz
Journal:  DNA Repair (Amst)       Date:  2008-05-23

6.  The association between the APE1 Asp148Glu polymorphism and breast cancer susceptibility: a meta-analysis based on case-control studies.

Authors:  Zhiyong Zhao; Chuan Liu; Yong Zeng; Lei Gu; Mingzhen Ying; Ning Wang; Bin Hao; Huiyan Yao; Changqing Su; Yajie Wang; Yuchen Ma
Journal:  Tumour Biol       Date:  2014-01-14

7.  The association between the APE1 Asp148Glu polymorphism and prostate cancer susceptibility: a meta-analysis based on case-control studies.

Authors:  Xue Zhou; Li Wei; Guangjun Jiao; Wei Gao; Mingzhen Ying; Ning Wang; Yajie Wang; Chuan Liu
Journal:  Mol Genet Genomics       Date:  2014-09-19       Impact factor: 3.291

8.  A role for poly(ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression.

Authors:  C Nirodi; S NagDas; S P Gygi; G Olson; R Aebersold; A Richmond
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

Review 9.  Role of CXCL1 in tumorigenesis of melanoma.

Authors:  Punita Dhawan; Ann Richmond
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

10.  Biallelic mutations in DNA ligase 1 underlie a spectrum of immune deficiencies.

Authors:  Patrick Maffucci; Jose Chavez; Thomas J Jurkiw; Patrick J O'Brien; Jordan K Abbott; Paul R Reynolds; Austen Worth; Luigi D Notarangelo; Kerstin Felgentreff; Patricia Cortes; Bertrand Boisson; Lin Radigan; Aurélie Cobat; Chitra Dinakar; Mohammad Ehlayel; Tawfeg Ben-Omran; Erwin W Gelfand; Jean-Laurent Casanova; Charlotte Cunningham-Rundles
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.